+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Capillary Columns for Biopharmaceuticals Market - Global Forecast 2026-2032- Product Image
Capillary Columns for Biopharmaceuticals Market - Global Forecast 2026-2032- Product Image
Sale

Capillary Columns for Biopharmaceuticals Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6138909
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Capillary Columns for Biopharmaceuticals Market is projected to reach USD 490.86 Million in 2026. It is expected to continue growing at a CAGR of 9.65%, reaching USD 852.98 Million by 2032.

Capillary Columns for Biopharmaceuticals: Executive Overview

Capillary columns support high-resolution separation and characterization of biopharmaceuticals across analytical workflows such as liquid chromatography, gas chromatography, and specialized multidimensional methods. Their relevance is increasing as developers manage more complex molecules, stricter impurity profiles, advanced formulation systems, and demanding quality requirements. Adoption depends on resolving power, chemical compatibility, reproducibility, robustness, and integration with validated laboratory workflows.

Biopharmaceutical Complexity Is Reshaping Separation Workflows

The landscape is shifting from routine analysis toward characterization of increasingly diverse products, including proteins, peptides, oligonucleotides, antibody-based therapies, and other advanced modalities. This raises demand for columns that deliver consistent selectivity, low analyte interaction, efficient separations, and dependable performance across development, manufacturing support, and quality-control environments. Regulatory expectations for data integrity, method transfer, and lifecycle management are also encouraging more standardized and reproducible column selection and operating practices.

Artificial Intelligence Is Improving Method Development and Quality Control

Artificial intelligence can reduce experimental iteration by linking molecular attributes, historical chromatograms, instrument parameters, and column behavior to method-development decisions. In biopharmaceutical laboratories, machine-learning tools may help identify promising stationary phases, optimize gradients and temperatures, detect atypical peak patterns, and support predictive maintenance. The strongest practical value comes when AI remains connected to scientifically controlled workflows, with transparent training data, human review, validated models, and auditable records. AI does not remove the need for orthogonal characterization, reference standards, or regulatory documentation.

Regional Patterns Reflect Uneven Biopharmaceutical Capability and Regulation

North America combines advanced biologics development, sophisticated analytical laboratories, and mature quality systems, supporting demand for high-performance and reproducible capillary-column workflows. Europe benefits from strong pharmaceutical research networks and harmonized regulatory expectations, while Asia-Pacific is expanding analytical capacity alongside biopharmaceutical manufacturing and research growth. Latin America is developing specialized capabilities unevenly, with adoption influenced by access to instruments, technical expertise, and imported laboratory supplies. The Middle East is building research and manufacturing infrastructure in selected hubs, whereas Africa remains more variable, with opportunities linked to laboratory modernization, workforce development, and regional quality initiatives.

Economic and Regulatory Groups Shape Access and Standardization

ASEAN countries are strengthening regional pharmaceutical and laboratory capabilities, although purchasing conditions, technical support, and regulatory implementation differ across members. BRICS economies combine substantial scientific capacity with varied industrial bases, creating distinct requirements for localization, training, and supply resilience. The European Union benefits from regulatory coordination and cross-border research collaboration. G7 members generally have advanced analytical infrastructure and high expectations for method robustness and documentation. GCC states are investing in healthcare and life-science capacity, while NATO members span mature and developing laboratory ecosystems, making interoperability, procurement resilience, and technical training important considerations.

Country-Level Differences Define Adoption Priorities

The United States and Canada have strong biopharmaceutical research and quality-control ecosystems, with emphasis on reproducibility, automation, and validated methods. Germany, France, Italy, Spain, and the United Kingdom operate within sophisticated European analytical and regulatory environments, while differing in procurement structures and laboratory specialization. China and India are expanding biopharmaceutical development, manufacturing, and analytical capabilities, increasing the importance of scalable workflows and local technical support. Japan and South Korea bring advanced instrumentation, precision manufacturing, and demanding quality practices. Australia supports specialized research and translational activity. Brazil and Mexico are strengthening local pharmaceutical and laboratory capacity, with adoption shaped by infrastructure, import processes, and workforce availability. Russia’s analytical environment is influenced by domestic capability, supply-chain conditions, and access to specialized technologies.

Prioritize Reproducibility, Workflow Fit, and Regional Resilience

Industry leaders should select capillary columns against clearly defined analyte, matrix, resolution, throughput, and compatibility requirements rather than relying on nominal specifications alone. Qualification programs should compare lot-to-lot consistency, lifetime, pressure behavior, carryover, recovery, and method-transfer performance under realistic conditions. Laboratories can improve resilience by maintaining qualified alternatives, documenting storage and handling practices, and developing regional technical-support plans. Investment in analyst training, standardized data systems, and controlled AI-assisted method development can further improve productivity without weakening validation, traceability, or scientific oversight.

Methodology: Evidence-Led Assessment of Technology and Adoption Drivers

This executive summary uses a structured qualitative assessment of capillary-column applications in biopharmaceutical analysis. The approach considers product complexity, analytical requirements, regulatory expectations, laboratory infrastructure, regional industrial conditions, and the potential role of artificial intelligence. Regional, group, and country interpretations are framed around documented characteristics of biopharmaceutical research, manufacturing, quality systems, and scientific capacity. Claims are limited to directional insights; no market estimates, shares, forecasts, or company-specific assessments are included.

Strategic Outlook for Capillary-Column Users

Capillary columns will remain important where biopharmaceutical laboratories require selective, reproducible, and traceable separations for complex molecules and demanding quality decisions. The most durable advantage will come from combining suitable column chemistry with disciplined method development, robust instrument control, skilled personnel, and well-governed data practices. Organizations that align technical performance with validation, supply continuity, regional requirements, and responsible AI adoption will be better positioned to improve analytical reliability as biopharmaceutical workflows continue to evolve.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Capillary Columns for Biopharmaceuticals Market, by Column Type
7.1. Introduction
7.2. Fused Silica
7.3. Metal
7.4. Polymer
8. Capillary Columns for Biopharmaceuticals Market, by Particle Size
8.1. Introduction
8.2. Less Than 3 µm
8.3. 3 To 5 µm
8.4. More Than 5 µm
9. Capillary Columns for Biopharmaceuticals Market, by Stationary Phase
9.1. Introduction
9.2. Ionic Liquid
9.3. Metal Oxide
9.4. Polymer-Based
9.5. Silica-Based
10. Capillary Columns for Biopharmaceuticals Market, by Application
10.1. Introduction
10.2. Bioanalysis
10.3. Metabolite Profiling
10.4. Purity Analysis
10.5. Quality Control
10.5.1. Assay Validation
10.5.2. Stability Testing
10.6. Research And Development
10.6.1. Method Development
10.6.2. Method Optimization
11. Capillary Columns for Biopharmaceuticals Market, by End User
11.1. Introduction
11.2. Academic And Research Institutions
11.3. Biotech Companies
11.4. Contract Research Organizations
11.5. Pharmaceutical Companies
12. Capillary Columns for Biopharmaceuticals Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Capillary Columns for Biopharmaceuticals Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Capillary Columns for Biopharmaceuticals Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies, Inc.
16.2. Bio-Rad Laboratories, Inc.
16.3. Bio-Techne Corporation
16.4. Danaher Corporation
16.5. Dikma Technologies Inc.
16.6. GL Sciences Inc.
16.7. Hichrom Ltd.
16.8. Macherey-Nagel GmbH & Co. KG
16.9. Merck KGaA
16.10. PerkinElmer, Inc.
16.11. QIAGEN N.V.
16.12. Restek Corporation
16.13. SGE Analytical Science Pty Ltd
16.14. Shimadzu Corporation
16.15. Shiseido Company, Limited
16.16. Thermo Fisher Scientific Inc.
16.17. Tosoh Corporation
16.18. Trajan Scientific and Medical Pty Ltd
16.19. VICI AG International
16.20. Waters Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Capillary Columns for Biopharmaceuticals Market, Years Considered for the Study
FIGURE 2. Global Capillary Columns for Biopharmaceuticals Market, Research Design
FIGURE 3. Global Capillary Columns for Biopharmaceuticals Market, Research Framework
FIGURE 4. Global Capillary Columns for Biopharmaceuticals Market, Data Triangulation
FIGURE 5. Global Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2025 vs 2032 (%)
FIGURE 7. Global Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2025 vs 2032 (%)
FIGURE 9. Global Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2025 vs 2032 (%)
FIGURE 11. Global Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Capillary Columns for Biopharmaceuticals Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Capillary Columns for Biopharmaceuticals Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Capillary Columns for Biopharmaceuticals Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Capillary Columns for Biopharmaceuticals Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Capillary Columns for Biopharmaceuticals Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Capillary Columns for Biopharmaceuticals Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Capillary Columns for Biopharmaceuticals Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Capillary Columns for Biopharmaceuticals Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Capillary Columns for Biopharmaceuticals Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Capillary Columns for Biopharmaceuticals Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Capillary Columns for Biopharmaceuticals Market Segmentation & Coverage
TABLE 2. Global Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 3. Global Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 4. Global Fused Silica Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Fused Silica Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Fused Silica Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Metal Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Metal Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Metal Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 14. Global Less Than 3 µm Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Less Than 3 µm Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Less Than 3 µm Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global 3 To 5 µm Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global 3 To 5 µm Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global 3 To 5 µm Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global More Than 5 µm Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global More Than 5 µm Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global More Than 5 µm Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 24. Global Ionic Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Ionic Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Ionic Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Metal Oxide Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Metal Oxide Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Metal Oxide Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Polymer-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Polymer-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Polymer-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Silica-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Silica-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Silica-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 37. Global Bioanalysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Bioanalysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Bioanalysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Metabolite Profiling Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Metabolite Profiling Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Metabolite Profiling Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Purity Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Purity Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Purity Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Quality Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Assay Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Assay Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Assay Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Stability Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Stability Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Stability Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Research And Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Research And Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Research And Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Method Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Method Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Method Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Method Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Method Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Method Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Global Academic And Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Academic And Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Academic And Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Capillary Columns for Biopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Capillary Columns for Biopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. North America Capillary Columns for Biopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. North America Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 88. North America Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 89. North America Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 90. North America Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. North America Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 92. North America Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 93. North America Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Latin America Capillary Columns for Biopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Latin America Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 96. Latin America Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 97. Latin America Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 98. Latin America Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. Latin America Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 100. Latin America Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 101. Latin America Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Europe Capillary Columns for Biopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Europe Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 104. Europe Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 105. Europe Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 106. Europe Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. Europe Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 108. Europe Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 109. Europe Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Middle East Capillary Columns for Biopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Middle East Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 112. Middle East Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 113. Middle East Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 114. Middle East Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. Middle East Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 116. Middle East Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 117. Middle East Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. Africa Capillary Columns for Biopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Africa Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 120. Africa Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 121. Africa Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 122. Africa Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 123. Africa Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 124. Africa Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 125. Africa Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Global Capillary Columns for Biopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. ASEAN Capillary Columns for Biopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. ASEAN Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 129. ASEAN Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 130. ASEAN Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 131. ASEAN Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. ASEAN Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 133. ASEAN Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 134. ASEAN Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. GCC Capillary Columns for Biopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. GCC Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 137. GCC Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 138. GCC Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 139. GCC Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. GCC Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 141. GCC Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 142. GCC Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. European Union Capillary Columns for Biopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. European Union Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 145. European Union Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 146. European Union Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 147. European Union Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. European Union Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 149. European Union Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 150. European Union Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. BRICS Capillary Columns for Biopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. BRICS Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 153. BRICS Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 154. BRICS Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 155. BRICS Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. BRICS Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 157. BRICS Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 158. BRICS Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. G7 Capillary Columns for Biopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. G7 Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 161. G7 Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 162. G7 Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 163. G7 Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. G7 Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 165. G7 Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 166. G7 Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. NATO Capillary Columns for Biopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. NATO Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 169. NATO Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 170. NATO Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 171. NATO Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. NATO Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 173. NATO Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 174. NATO Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Global Capillary Columns for Biopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. United States Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 177. United States Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 178. United States Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 179. United States Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 180. United States Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. United States Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 182. United States Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 183. United States Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Canada Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 185. Canada Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 186. Canada Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 187. Canada Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 188. Canada Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. Canada Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 190. Canada Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 191. Canada Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Mexico Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 193. Mexico Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 194. Mexico Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 195. Mexico Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 196. Mexico Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. Mexico Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 198. Mexico Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 199. Mexico Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Brazil Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 201. Brazil Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 202. Brazil Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 203. Brazil Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 204. Brazil Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Brazil Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 206. Brazil Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 207. Brazil Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. United Kingdom Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 209. United Kingdom Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 210. United Kingdom Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 211. United Kingdom Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 212. United Kingdom Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. United Kingdom Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 214. United Kingdom Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 215. United Kingdom Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Germany Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 217. Germany Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 218. Germany Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 219. Germany Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 220. Germany Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. Germany Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 222. Germany Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 223. Germany Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. France Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 225. France Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 226. France Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 227. France Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 228. France Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. France Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 230. France Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 231. France Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. Russia Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 233. Russia Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 234. Russia Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 235. Russia Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 236. Russia Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. Russia Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 238. Russia Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 239. Russia Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Italy Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 241. Italy Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 242. Italy Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 243. Italy Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 244. Italy Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. Italy Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 246. Italy Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 247. Italy Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Spain Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 249. Spain Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 250. Spain Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 251. Spain Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 252. Spain Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. Spain Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 254. Spain Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 255. Spain Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. China Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 257. China Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 258. China Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 259. China Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 260. China Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. China Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 262. China Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 263. China Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. India Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 265. India Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 266. India Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 267. India Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 268. India Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. India Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 270. India Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 271. India Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Japan Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 273. Japan Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 274. Japan Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 275. Japan Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 276. Japan Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. Japan Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 278. Japan Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 279. Japan Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. Australia Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 281. Australia Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 282. Australia Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 283. Australia Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 284. Australia Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 285. Australia Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 286. Australia Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 287. Australia Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 288. South Korea Capillary Columns for Biopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 289. South Korea Capillary Columns for Biopharmaceuticals Market Size, by Column Type, 2017-2032 (USD Million)
TABLE 290. South Korea Capillary Columns for Biopharmaceuticals Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 291. South Korea Capillary Columns for Biopharmaceuticals Market Size, by Stationary Phase, 2017-2032 (USD Million)
TABLE 292. South Korea Capillary Columns for Biopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. South Korea Capillary Columns for Biopharmaceuticals Market Size, by Quality Control, 2017-2032 (USD Million)
TABLE 294. South Korea Capillary Columns for Biopharmaceuticals Market Size, by Research And Development, 2017-2032 (USD Million)
TABLE 295. South Korea Capillary Columns for Biopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. Global Capillary Columns for Biopharmaceuticals Market Share, by Key Player, 2025
TABLE 297. Global Capillary Columns for Biopharmaceuticals Market, Key Experts

Companies Mentioned

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Danaher Corporation
  • Dikma Technologies Inc.
  • GL Sciences Inc.
  • Hichrom Ltd.
  • Macherey-Nagel GmbH & Co. KG
  • Merck KGaA
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Restek Corporation
  • SGE Analytical Science Pty Ltd
  • Shimadzu Corporation
  • Shiseido Company, Limited
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Trajan Scientific and Medical Pty Ltd
  • VICI AG International
  • Waters Corporation

Related Topics

Related Reports

Biopharmaceutical Market Outlook to 2029 - Product Image

Biopharmaceutical Market Outlook to 2029

  • Report
  • 97 Pages
  • Global
From
North America Biopharmaceuticals Market Forecast to 2028 -Regional Analysis - Product Image

North America Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

  • Report
  • 224 Pages
  • North America
From
Asia Pacific Biopharmaceuticals Market Forecast to 2028 -Regional Analysis - Product Image

Asia Pacific Biopharmaceuticals Market Forecast to 2028 -Regional Analysis

  • Report
  • 250 Pages
  • Asia Pacific
From
Biopharmaceutical Fermentation System Market - Global Forecast 2026-2032 - Product Image

Biopharmaceutical Fermentation System Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Biopharmaceutical Process Analytical Technology Market - Global Forecast 2026-2030 - Product Image

Biopharmaceutical Process Analytical Technology Market - Global Forecast 2026-2030

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.